Readystate Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$665K Buy
+10,600
New +$848K 0.03% 533
2025
Q2
Sell
-25,100
Closed -$2.53M 655
2025
Q1
$2.53M Sell
25,100
-33,600
-57% -$3.38M 0.08% 295
2024
Q4
$5.24M Sell
58,700
-80,100
-58% -$7.05M 0.16% 137
2024
Q3
$11.6M Buy
138,800
+77,000
+125% +$6.07M 0.22% 198
2024
Q2
$4.76M Buy
61,800
+16,100
+35% +$1.18M 0.15% 114
2024
Q1
$3.13M Buy
+45,700
New +$2.94M 0.04% 459
2023
Q2
Sell
-6,600
Closed -$330K 294
2023
Q1
$330K Buy
+6,600
New +$311K 0.03% 190

Other funds holding BSX

Readystate Asset Management's BSX Position: Q1 2026 in Review

Readystate Asset Management opened a new position in Boston Scientific (BSX) in Q1 2026: 3,540 shares worth $222K. The stake represents 0.01% of the portfolio and ranks #735 among its holdings. This is a return to the name: Readystate Asset Management previously reported a position in BSX as recently as Q1 2025.

Readystate Asset Management first reported a position in BSX in Q1 2025 and has held it in 2 quarters since. The position peaked at $285K in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Readystate Asset Management held 3,540 shares of Boston Scientific worth $222K as of Q1 2026.
  • Boston Scientific was a new Readystate Asset Management position in Q1 2026.
  • Boston Scientific made up 0.01% of Readystate Asset Management's portfolio in Q1 2026, its #735 holding.
  • Readystate Asset Management first reported a position in Boston Scientific in Q1 2025 and has held it in 2 quarters since.
  • Readystate Asset Management's Boston Scientific position peaked at $285K in Q1 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Readystate Asset Management's 13F filing for Q1 2026, filed 15 May 2026.